We identified TFs that are known cancer drivers such as STAT5 (endometrioid carcinoma17), AHR18, HMGA19 (KIRC), PBX1 (OV20, prostate cancer21, BRCA22, 23) and NFE2L2 (squamous cell lung cancer). Here, NFE2L2 is linked to cancer.